Extraintestinal manifestations of inflammatory bowel disease - PubMed (original) (raw)

Extraintestinal manifestations of inflammatory bowel disease

Jonathan S Levine et al. Gastroenterol Hepatol (N Y). 2011 Apr.

Abstract

Extraintestinal manifestations of inflammatory bowel disease are prevalent in both ulcerative colitis and Crohn's disease. The most common manifestations involve the musculoskeletal and dermatologic systems. Other manifestations involve the hepatopan-creatobiliary system (eg, primary sclerosing cholangitis) as well as the ocular, renal, and pulmonary systems. A multidisciplinary team approach is often needed for effective management, and emergency situations require prompt evaluation.

Keywords: Inflammatory bowel disease; arthritis; dermatology; extraintestinal manifestations; primary sclerosing cholangitis.

PubMed Disclaimer

Figures

Figure 1

The American Gastroenterological Association's recommendations for management of osteoporosis in IBD patients.

CS

corticosteroid

DEXA

dual-energy X-ray absorptiometry

IBD

inflammatory bowel disease.

Modified from Bernstein CN, et al.

Similar articles

• A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease.
  Annese V. Annese V. Saudi J Med Med Sci. 2019 May-Aug;7(2):66-73. doi: 10.4103/sjmms.sjmms_81_18. Epub 2019 Apr 12. Saudi J Med Med Sci. 2019. PMID: 31080385 Free PMC article. Review.
• [Extraintestinal manifestations of inflammatory bowel disease].
  Rogler G, Schölmerich J. Rogler G, et al. Med Klin (Munich). 2004 Mar 15;99(3):123-30. doi: 10.1007/s00063-004-1003-2. Med Klin (Munich). 2004. PMID: 15024484 Review. German.
• Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.
  Guillo L, D'Amico F, Serrero M, Angioi K, Loeuille D, Costanzo A, Danese S, Peyrin-Biroulet L. Guillo L, et al. United European Gastroenterol J. 2020 Nov;8(9):1013-1030. doi: 10.1177/2050640620950093. Epub 2020 Aug 10. United European Gastroenterol J. 2020. PMID: 32778004 Free PMC article.
• Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
  Larsen S, Bendtzen K, Nielsen OH. Larsen S, et al. Ann Med. 2010 Mar;42(2):97-114. doi: 10.3109/07853890903559724. Ann Med. 2010. PMID: 20166813 Review.
• Patient awareness of extraintestinal manifestations of inflammatory bowel disease.
  Huang V, Mishra R, Thanabalan R, Nguyen GC. Huang V, et al. J Crohns Colitis. 2013 Sep;7(8):e318-24. doi: 10.1016/j.crohns.2012.11.008. Epub 2012 Dec 21. J Crohns Colitis. 2013. PMID: 23265763

Cited by

• Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
  Argüelles-Arias F, Castro-Laria L, Lobatón T, Aguas-Peris M, Rojas-Feria M, Barreiro-de Acosta M, Soto-Escribano P, Calvo-Moya M, Ginard-Vicens D, Chaparro-Sánchez M, Hernández-Durán M, Castro-Senosiain B, Fernández-Villaverde A, García-Sánchez V, Domínguez-Muñoz E, Caunedo-Álvarez A, Herrerías-Gutiérrez JM. Argüelles-Arias F, et al. Dig Dis Sci. 2013 Oct;58(10):2949-54. doi: 10.1007/s10620-013-2762-2. Epub 2013 Jul 5. Dig Dis Sci. 2013. PMID: 23828140
• Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.
  Freitas TH, Andreoulakis E, Alves GS, Miranda HL, Braga LL, Hyphantis T, Carvalho AF. Freitas TH, et al. World J Gastroenterol. 2015 Jun 7;21(21):6713-27. doi: 10.3748/wjg.v21.i21.6713. World J Gastroenterol. 2015. PMID: 26074710 Free PMC article.
• Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.
  Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, Brauer M, Baldassano RN. Lichtenstein GR, et al. Gastroenterol Hepatol (N Y). 2022 Jan;18(1):32-43. Gastroenterol Hepatol (N Y). 2022. PMID: 35505770 Free PMC article.
• Systemic instruction of cell-mediated immunity by the intestinal microbiome.
  Grainger J, Daw R, Wemyss K. Grainger J, et al. F1000Res. 2018 Dec 7;7:F1000 Faculty Rev-1910. doi: 10.12688/f1000research.14633.1. eCollection 2018. F1000Res. 2018. PMID: 30631436 Free PMC article. Review.
• Cutaneous Crohn Disease without Intestinal Manifestations.
  Vahabi-Amlashi S, Molkara S, Shahrokhi Y. Vahabi-Amlashi S, et al. Adv Biomed Res. 2021 Nov 26;10:39. doi: 10.4103/abr.abr_180_19. eCollection 2021. Adv Biomed Res. 2021. PMID: 35071107 Free PMC article.

References

1. 1. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116–1122. - PubMed
2. 1. Isaacs KL. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? Inflamm Bowel Dis. 2008;14(suppl 2):S198–S199. - PubMed
3. 1. Monsén U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990;85:711–716. - PubMed
4. 1. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691–1695. - PubMed
5. 1. Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol. 1988;83:216–223. - PubMed

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central